| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.006 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |